If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Neoen S.A. NEOEN Apr 25, 2025 39.00 0.00   
 Neolife ALNLF Apr 25, 2025 0.08 0.00   
 Neovacs ALNEV Apr 25, 2025 0.01 -23.08   
 Netgem ALNTG Apr 25, 2025 0.96 +1.55   
 NetMedia Group ALNMG Apr 25, 2025 1.35 +0.73   
 Neurones NRO Apr 25, 2025 46.70 +0.11   
 Nexans SA NEX Apr 25, 2025 90.90 +1.91   
 Nexity SA NXI Apr 25, 2025 8.98 -3.08   
 Next 150 Index N150 Apr 25, 2025 3 349.93 +0.72   
 Nextedia ALNXT Apr 25, 2025 0.51 -0.79   
 NFL Biosciences S.A. ALNFL Apr 25, 2025 1.50 +3.45   
 Nicolas Miguet and Associes S.A MLNMA Apr 25, 2025 0.15 -20.21   
 Nicox SA ALCOX Apr 25, 2025 0.23 +3.54   
 Nokia NOKIA Apr 25, 2025 4.38 +3.08   
 Novabase - Sociedade Gestora De Participacoes Sociais, S.A. NBA Apr 25, 2025 7.60 -0.65   
 Novacyt ALNOV Apr 25, 2025 0.47 -2.11   
 Novatech Industries MLNOV Apr 25, 2025 10.00 0.00   
 NR 21 NR21 Apr 25, 2025 34.00 0.00   
 NRJ Group NRG Apr 25, 2025 6.54 -2.10   
 NSC Groupe ALNSC Apr 25, 2025 63.50 0.00   
 NSE SA ALNSE Apr 25, 2025 43.00 +0.47   
 Obiz ALBIZ Apr 25, 2025 4.38 -0.45   
 Odyssee Technologies S.A. ALODY Apr 25, 2025 19.00 +1.17   
 Oeneo SBT Apr 25, 2025 9.00 -0.66   
 Omer-Decugis & Cie ALODC Apr 25, 2025 4.28 +1.18   
 Oncodesign Precision Medicine S.A ALOPM Apr 25, 2025 0.38 +2.43   
 One Experience ALEXP Apr 25, 2025 0.30 +2.74   
 Onlineformapro MLONL Apr 25, 2025 0.90 0.00   
 OPmobility OPM Apr 25, 2025 9.59 -0.52   
 Orange. ORA Apr 25, 2025 12.33 -2.95   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.